100
Participants
Start Date
January 6, 2014
Primary Completion Date
September 6, 2015
Study Completion Date
October 6, 2015
Rocuronium 0,6mg/kg
patients at days 8 to 14 of the menstrual cycle were considered to be at the follicular phase and Rocuronium 0,6mg/kg intravenous was applied
Rocuronium 0,6mg/kg
patients at days 18 to 24 of the menstrual cycle were considered to be at the luteal phase and Rocuronium 0,6mg/kg intravenous rocuronium was applied
Adnan Menderes University Training and Research Hospital, Aydin
Aydin Adnan Menderes University
OTHER